Hydroxyurea to Treat Beta-Thalassemia (Cooley's Anemia)

NCT00001958 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

100

Enrollment

NIH

Sponsor class

Conditions

Beta Thalassemia
Hemoglobinopathy

Interventions

DRUG: Hydroxyurea

Sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)